The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia
Lia Endriyani MSN
Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Search for more papers by this authorChing-Hui Chien RN, PhD
Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Search for more papers by this authorCorresponding Author
Xuan-Yi Huang RN, MSN, DNSc
Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Correspondence
Xuan-Yi Huang, RN, MSN, DNSc, Professor, Department of Nursing, National Taipei University of Nursing and Health Sciences, Taiwan, 365, Ming Te Road, 11219, Peitou, Taipei, Taiwan.
Email: [email protected]
Search for more papers by this authorLiu Chieh-Yu PhD
Graduate Institute of Nurse-Midwifery, National Taipei University of Nursing and Health Sciences,, Taipei, Taiwan
Search for more papers by this authorLia Endriyani MSN
Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Search for more papers by this authorChing-Hui Chien RN, PhD
Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Search for more papers by this authorCorresponding Author
Xuan-Yi Huang RN, MSN, DNSc
Department of Nursing, National Taipei University of Nursing and Health Sciences, Taipei, Taiwan
Correspondence
Xuan-Yi Huang, RN, MSN, DNSc, Professor, Department of Nursing, National Taipei University of Nursing and Health Sciences, Taiwan, 365, Ming Te Road, 11219, Peitou, Taipei, Taiwan.
Email: [email protected]
Search for more papers by this authorLiu Chieh-Yu PhD
Graduate Institute of Nurse-Midwifery, National Taipei University of Nursing and Health Sciences,, Taipei, Taiwan
Search for more papers by this authorAbstract
Purpose
Investigating factors that can predict medication adherence and quality of life, as well as the influence of adherence to medication on the quality of life among patients with schizophrenia.
Design and Methods
This study applies descriptive cross-sectional design. Participants were determined from outpatient clinic in a psychiatric hospital in Indonesia. Several questionnaires were used, including self-report, Glasgow Antipsychotics Side-effect Scale, drug attitude inventory and SQOL-18.
Findings
Side-effect factor (p < .05) could influence medication adherence. Residential area (p < .05) could significantly influence quality of life. There was also a correlation between medication adherence and quality of life (p < .05).
Practice Implications
Findings suggest to put more emphasis on assessing medication side effects.
CONFLICT OF INTEREST STATEMENT
The authors report no actual or potential conflict of interest.
REFERENCES
- 1Elder R, Evans K, Nizette D. Psychiatric and Mental Health Nursing. Australia: Elsevier; 2008.
- 2Gorostiaga A, Balluerka N, Guilera G, Aliri J, Barrios M. Functioning in patients with schizophrenia: a systematic review of the literature using the International Classification of Functioning, Disability and Health (ICF) as a reference. Qual Life Res. 2017; 26(3): 531–543. https://doi.org/10.1007/s11136-016-1488-y
- 3Adelufosi AO, Ogunwale A, Abayomi O, Mosanya JT. Socio-demographic and clinical correlates of subjective quality of life among Nigerian outpatients with schizophrenia. Schizophr Res. 2013; 209(3): 320–325. https://doi.org/10.1016/j.psychres.2012.12.027
- 4Boyer L, Aghababian V, Richieri R, et al. Insight into illness, neurocognition and quality of life in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2012; 36(2): 271–276. https://doi.org/10.1016/j.pnpbp.2011.10.008
- 5Suttajit S, Pilakanta S. Predictors of quality of life among individuals with schizophrenia. Neuropsychiatr Dis Treat. 2015; 11: 1371–1379. https://doi.org/10.2147/ndt.s81024
- 6Dossenbach M, Arango-Davila C, Ibarra HS, et al. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidol: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. J Clin Psychiatry. 2005; 66(8): 1021–1030. https://doi.org/10.4088/JCP.v66n0810
- 7Osman CB, Badli MM, Ainsah O, et al. The comparison of quality of life among patients with chizophrenia and major mood disorder in remission in hospital Universiti Kebangsaan Malaysia, Kuala Lumpur. Hong Kong J Psychiatry. 2009; 19(1): 4–10.
- 8Holubova M, Prasko J, Matousek S, et al Comparison of self-stigma and quality of life in patients with depressive disorders and schizophrenia spectrum disorders – a cross-sectional study. Neuropsychiatr Dis Treat. 2016; 12: 3021–3030. https://doi.org/10.2147/ndt.s121556
- 9Becker T, Leese M, Krumm S, et al. Needs and quality of life among patients with schizophrenia in five European centres. Soc Psychiatry Psychiatr Epidemiol. 2005; 40(8): 628–634. https://doi.org/10.1007/s00127-005-0937-7
- 10Dewi S, Elvira SD, Budiman R. The needs of schizophrenic people. J Indonesian Med Assoc. 2013; 63(03).
- 11Galuppi A, Turola MC, Nanni MG, Mazzoni P, Grassi L. Schizophrenia and quality of life: how important are symptoms and functioning. Int J Ment Health Syst. 2010; 4(1): 31. https://doi.org/10.1186/1752-4458-4-31
- 12Staring A, Mulder C, Duivenvoorden H, et al.. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication adherence and quality of life. Schizophr Res. 2009; 113(1): 27–33. https://doi.org/10.1016/j.schres.2009.05.022
- 13Lasebikan VO, Owoaje ET. Quality of life in psychosis: prevalence and associated factors in a Nigerian clinical population. Community Ment Health J. 2015; 51(4): 491–496. https://doi.org/10.1007/s10597-015-9842-z
- 14McCann TV, Clark E, Lu S. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia. J Adv Nurs. 2009; 65(3): 534–543. https://doi.org/10.1111/j.1365-2648.2008.04906.x
- 15Xiao J, Mi W, Li L, Shi Y, Zhang H. High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China. Neuropsychiatr Dis Treat. 2015; 11: 1161–1167. https://doi.org/10.2147/ndt.s72367
- 16McCann T, Boardman G, Clark E, Lu S. Risk profiles for non-adherence to antipsychotic medications. J Psychiatr Ment Health Nurs. 2008; 15(8): 622–629. https://doi.org/10.1111/j.1365-2850.2008.01277.x
- 17Brain C, Allerby K, Sameby B, et al. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(R)) in the Swedish COAST-study. Eur Neuropsychopharmacol. 2013; 23(12): 1754–1762. https://doi.org/10.1016/j.euroneuro.2013.09.001
- 18Iasevoli F, Fagiolini A, Formato MV, et al. Assessing patient-rated vs. clinician-rated adherence to the therapy in treatment resistant schizophrenia, schizophrenia responders, and non-schizophrenia patients. Schizophr Res. 2017; 249: 159–166. https://doi.org/10.1016/j.psychres.2017.01.015
- 19Dewi R, Marchira CR. Family histories of mental disorder and relapse in schizophrenic patient in Sardjito hospital Yogyakarta. Berita Kedokteran Masyarakat. 2012; 25(4): 176–179.
- 20Anwar Z, Amelia DR. Relaps pada pasien skizofrenia. Jurnal Ilmiah Psikologi Terapan. 2013; 1(1).
- 21 World Health Organization. The World Health Report 2001 – Mental health: new understanding, new hope. Geneva: World Health Organization; 2001
- 22 World Health Organization. WHO Library Cataloguing-in-Publication Data- Mental health action plan 2013–2020. Geneva: World Health Organization; 2013
- 23Waddell L, Taylor M. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol. 2008; 22(3): 238–243. https://doi.org/10.1177/0269881107087976
- 24Hogan TP, Awad AG, Eastwood R. A self-report scale predictive of drug adherence in schizophrenics: reliability and discriminative validity. Psychol Med. 1983; 13(01): 177–183. https://doi.org/10.1017/S0033291700050182
- 25Puschner B, Born A, Giebler A, Helm H, Leese M, Bindman JP, Burti L. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study. J Nerv Ment Dis. 2006; 194(10): 746–752. https://doi.org/10.1097/01.nmd.0000243082.75008.e7
- 26Puschner B, Angermeyer MC, Leese M, et al. Course of adherence to medication and quality of life in people with schizophrenia. Psychiatry Res. 2009; 165(3): 224–233. https://doi.org/10.1016/j.psychres.2007.10.011
- 27Lambert M, Conus P, Eide P, et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry. 2004; 19(7): 415–422. https://doi.org/10.1016/j.eurpsy.2004.06.031
- 28Fenton WS, Blyler CR, Heinssen RK. Determinants of medication adherence in schizophrenia: Empirical and clinical findings. Schizophr Bull. 1997; 23(4): 637–651. https://doi.org/10.1093/schbul/23.4.637
- 29Alene M, Wiese MD, Angamo MT, et al Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population. BMC Pharmacol Toxicol. 2012; 12(1): 10. https://doi.org/10.1186/1472-6904-12-10
- 30Mubarak AR, Baba I, Chin LH, Hoe QS. Quality of life of community-based chronic schizophrenia patients in Penang, Malaysia. Aust N Z J Psychiatry. 2003; 37(5): 577–585. https://doi.org/10.1046/j.1440-1614.2003.01228.x
- 31Irmansyah I, Prasetyo YA, Minas H. Human rights of persons with mental illness in Indonesia: more than legislation is needed. Int J Ment Health Syst. 2009; 3: 14. https://doi.org/10.1186/1752-4458-3-14
- 32Tempier R, Caron J, Mercier C, Leouffre P. Quality of life of severely mentally ill individuals: A comparative study. Community Ment Health J. 1998; 34(5): 477–485.
- 33Adelufosi AO, Adebowale TO, Abayomi O, Mosanya JT. Medication adherence and quality of life among Nigerian outpatients with schizophrenia. Gen Hosp Psychiatry. 2012; 34(1): 72–79. https://doi.org/10.1016/j.genhosppsych.2011.09.001
- 34Boyer L, Simeoni MC, Loundou A, et al. The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res. 2010; 121(1): 241–250. https://doi.org/10.1016/j.schres.2010.05.019